Qu Tian1, Susan M Resnick2, Murat Bilgel2,3, Dean F Wong4,5,6,7,8, Luigi Ferrucci1, Stephanie A Studenski1. 1. Longitudinal Studies Section, Translational Gerontology Branch and. 2. Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland. 3. Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland. 4. Department of Radiology, Section of High Resolution Brain Imaging. 5. Department of Psychiatry. 6. Department of Neuroscience. 7. Department of Neurology, and. 8. Department of Environmental Health Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Abstract
BACKGROUND: Motor slowing is associated with risk of Alzheimer's disease. Whether β-amyloid (Aβ) burden is associated with motor decline, independent of cognitive decline, is unknown. METHODS: About 59 cognitively unimpaired older participants had baseline PET-PiB scans and repeated measures of lower (usual gait speed, 400-m time, Health ABC Physical Performance Battery (HABCPPB) score, total standing balance time) and upper (mean tapping time) extremity performance during a mean follow-up of 4.7 years. Linear mixed effect models examined the relationship between baseline Aβ burden and motor decline, adjusting for age, sex, body mass index, cardiovascular risk, APOE ɛ4 status, memory decline, depressive symptoms, ankle-arm index, processing speed, executive function, and cerebrovascular disease. RESULTS: Higher mean cortical Aβ burden was associated with greater declines in gait speed and HABCPPB score and a greater increase in 400-m time. Higher Aβ of putamen was associated with declines in all lower extremity measures, including balance. Higher Aβ of dorsolateral prefrontal cortex and lateral temporal lobe was associated with declines of gait speed and 400-m time, and of precuneus with a greater increase in 400-m time. Associations remained similar after further adjustment. CONCLUSIONS: In cognitively unimpaired older adults, Aβ burden overall and in specific brain regions are risk factors for lower extremity motor decline, independent of memory function. These findings provide the first empirical evidence that Aβ burden is a risk factor for mobility decline in older adults. Published by Oxford University Press on behalf of The Gerontological Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Motor slowing is associated with risk of Alzheimer's disease. Whether β-amyloid (Aβ) burden is associated with motor decline, independent of cognitive decline, is unknown. METHODS: About 59 cognitively unimpaired older participants had baseline PET-PiB scans and repeated measures of lower (usual gait speed, 400-m time, Health ABC Physical Performance Battery (HABCPPB) score, total standing balance time) and upper (mean tapping time) extremity performance during a mean follow-up of 4.7 years. Linear mixed effect models examined the relationship between baseline Aβ burden and motor decline, adjusting for age, sex, body mass index, cardiovascular risk, APOE ɛ4 status, memory decline, depressive symptoms, ankle-arm index, processing speed, executive function, and cerebrovascular disease. RESULTS: Higher mean cortical Aβ burden was associated with greater declines in gait speed and HABCPPB score and a greater increase in 400-m time. Higher Aβ of putamen was associated with declines in all lower extremity measures, including balance. Higher Aβ of dorsolateral prefrontal cortex and lateral temporal lobe was associated with declines of gait speed and 400-m time, and of precuneus with a greater increase in 400-m time. Associations remained similar after further adjustment. CONCLUSIONS: In cognitively unimpaired older adults, Aβ burden overall and in specific brain regions are risk factors for lower extremity motor decline, independent of memory function. These findings provide the first empirical evidence that Aβ burden is a risk factor for mobility decline in older adults. Published by Oxford University Press on behalf of The Gerontological Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Victor Aboyans; Michael H Criqui; Pierre Abraham; Matthew A Allison; Mark A Creager; Curt Diehm; F Gerry R Fowkes; William R Hiatt; Björn Jönsson; Philippe Lacroix; Benôit Marin; Mary M McDermott; Lars Norgren; Reena L Pande; Pierre-Marie Preux; H E Jelle Stoffers; Diane Treat-Jacobson Journal: Circulation Date: 2012-11-16 Impact factor: 29.690
Authors: C H Kawas; M M Corrada; R Brookmeyer; A Morrison; S M Resnick; A B Zonderman; D Arenberg Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: E M Simonsick; A B Newman; M C Nevitt; S B Kritchevsky; L Ferrucci; J M Guralnik; T Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2001-10 Impact factor: 6.053
Authors: Zhiqiang Lao; Dinggang Shen; Dengfeng Liu; Abbas F Jawad; Elias R Melhem; Lenore J Launer; R Nick Bryan; Christos Davatzikos Journal: Acad Radiol Date: 2008-03 Impact factor: 3.173
Authors: Clifford R Jack; Heather J Wiste; Stephen D Weigand; Walter A Rocca; David S Knopman; Michelle M Mielke; Val J Lowe; Matthew L Senjem; Jeffrey L Gunter; Gregory M Preboske; Vernon S Pankratz; Prashanthi Vemuri; Ronald C Petersen Journal: Lancet Neurol Date: 2014-09-04 Impact factor: 44.182
Authors: Qu Tian; Woei-Nan Bair; Susan M Resnick; Murat Bilgel; Dean F Wong; Stephanie A Studenski Journal: Gait Posture Date: 2018-02-06 Impact factor: 2.840
Authors: Alexandra M V Wennberg; Timothy G Lesnick; Christopher G Schwarz; Rodolfo Savica; Clinton E Hagen; Rosebud O Roberts; David S Knopman; John H Hollman; Prashanthi Vemuri; Clifford R Jack; Ronald C Petersen; Michelle M Mielke Journal: J Gerontol A Biol Sci Med Sci Date: 2018-08-10 Impact factor: 6.053
Authors: Aron S Buchman; Lei Yu; Robert S Wilson; Andrew Lim; Robert J Dawe; Chris Gaiteri; Sue E Leurgans; Julie A Schneider; David A Bennett Journal: Neurology Date: 2019-01-16 Impact factor: 9.910
Authors: Tina E Brinkley; Miles Berger; Kathryn E Callahan; Robert A Fieo; Lee A Jennings; Jill K Morris; Heather M Wilkins; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2018-08-10 Impact factor: 6.053
Authors: Fares Bassil; Hannah J Brown; Shankar Pattabhiraman; Joe E Iwasyk; Chantal M Maghames; Emily S Meymand; Timothy O Cox; Dawn M Riddle; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee Journal: Neuron Date: 2019-11-20 Impact factor: 17.173
Authors: David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Aron S Buchman; Robert J Dawe; Lei Yu; Andrew Lim; Robert S Wilson; Julie A Schneider; David A Bennett Journal: Neurology Date: 2018-04-25 Impact factor: 9.910